Sectors
IVVD
Invivyd, Inc.
0.67
2 x 0.41
2 x 0.75
bid
ask
+
0.06
10.04%
2 @ 04:00 AM
0.68 +0.01 (1.56%)
| Ytd | -72.92% | |
| 1y | -61.78% |
0.61
day range
0.68
0.53
52 week range
3.07
| Open | 0.62 | Prev Close | 0.61 | Low | 0.61 | High | 0.68 | Mkt Cap | 197.13M |
| Vol | 3.27M | Avg Vol | 5.02M | EPS | -0.33 | P/E | N/A | Forward P/E | -2.36 |
| Beta | 0.66 | Short Ratio | 23.71 | Inst. Own | 79.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 0.82 | 200-d Avg | 1.28 | 1yr Est | 5.89 |
IVVD News
benzinga.com
Invivyd And SPEAR Study Group Initiate FLINTLOCK Phase 2 Trial Evaluating Safety, Tolerability, Phar
The Phase 2 FLINTLOCK clinical trial includes the following study features:Randomized, double-blind,
globenewswire.com
Invivyd and the SPEAR Study Group Announce Initiation of “FLINTLOCK” Phase 2 Study of VYD2311, a Mon
NEW HAVEN, Conn., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) and the SPEAR Study
benzinga.com
Invivyd Outlines Accelerated Approval Submission Path with FDA for COVID-19 Antibody
Invivyd reported Phase 3 LIBERTY trial data for VYD2311, showing strong safety and enhanced COVID-19
benzinga.com
Invivyd Announces Clinically Meaningful And Statistically Significant Topline Data From Its LIBERTY
VYD2311 met all primary and secondary endpoints comparing VYD2311 to an mRNA-based COVID-19 vaccine,
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Greenland Mines (NASDAQ:GRML) stock rose 232.6% to $9.48 during Monday's regular sessio
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Greenland Mines (NASDAQ:GRML) stock rose 108.1% to $5.93 during Monday's pre-market ses